Home > Insider Trading > Filing (0001371285-20-000298)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371285	Trupanion Inc.	TRUP	Hospital & Medical Service Plans (6324)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622728	Asher Bearman	C/O Trupanion, Inc. 6100 4Th Avenue S, Suite 200 Seattle WA 98108	Chief Strategy Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-11-23	2,031	$7.78	6,162	No	4	M	Direct
Common Stock	Disposition	2020-11-23	2,031	$96.35	4,131	No	4	S	Direct
Common Stock	Acquisiton	2020-11-24	7,169	$7.78	11,300	No	4	M	Direct
Common Stock	Disposition	2020-11-24	7,169	$95.72	4,131	No	4	S	Direct
Common Stock	Acquisiton	2020-11-24	30,774	$17.97	34,905	No	4	M	Direct
Common Stock	Disposition	2020-11-24	30,774	$95.72	4,131	No	4	S	Direct
Common Stock	Acquisiton	2020-11-24	10,450	$15.46	14,581	No	4	M	Direct
Common Stock	Disposition	2020-11-24	10,450	$95.72	4,131	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-11-23	2,031	$0.00	2,031	$7.78
Common Stock	Stock Option (right to buy)	Disposition	2020-11-24	7,169	$0.00	7,169	$7.78
Common Stock	Stock Option (right to buy)	Disposition	2020-11-24	30,774	$0.00	30,774	$17.97
Common Stock	Stock Option (right to buy)	Disposition	2020-11-24	10,450	$0.00	10,450	$15.46

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,169	2025-07-24	No	4	M	Direct
0	2025-07-24	No	4	M	Direct
4,397	2027-05-04	No	4	M	Direct
0	2026-07-22	No	4	M	Direct

Footnotes

The sales reported were effected in order to allow the reporting person to enter into a real estate purchase.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.32 to $96.37 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.842 to $96.61 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
This stock option grant is fully vested.
The option vests as to 25% of the total shares on May 4, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on May 4, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.